Zhenlin Yan
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies
Papers in
- Hepatology 17
- Hepatocellular Carcinoma Treatment and Prognosis 17
- Surgery 10
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
- Co-authors
- Feng Shen (23 shared papers)Yong Xia (20 shared papers)Kui Wang (20 shared papers)Mengchao Wu (17 shared papers)Jun Li (14 shared papers)Lehua Shi (16 shared papers)Dong Wu (12 shared papers)Xuying Wan (14 shared papers)
- Journals
- Oncotarget (4 papers)Annals of Surgical Oncology (3 papers)Hepatology (2 papers)Journal of Gastroenterology and Hepatology (2 papers)HPB (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Zhenlin Yan
36 papers receiving 1.9k citations
Zhenlin Yan's Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 652
- Surgery 676
- Oncology 332
- Cancer Research 178
- Pulmonary and Respiratory Medicine 310
Countries citing papers authored by Zhenlin Yan
This map shows the geographic impact of Zhenlin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlin Yan more than expected).
Fields of papers citing papers by Zhenlin Yan
This network shows the impact of papers produced by Zhenlin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlin Yan. The network helps show where Zhenlin Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenlin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy Hit paper breakdown → | 2013 | 849 |
| 2 | 2014 | 135 | |
| 3 | 2019 | 132 | |
| 4 | 2010 | 94 | |
| 5 | 2012 | 67 | |
| 6 | 2010 | 65 | |
| 7 | 2020 | 56 | |
| 8 | 2015 | 50 | |
| 9 | 2016 | 44 | |
| 10 | 2015 | 38 | |
| 11 | 2016 | 38 | |
| 12 | 2016 | 38 | |
| 13 | 2012 | 34 | |
| 14 | 2017 | 31 | |
| 15 | 2014 | 28 | |
| 16 | 2016 | 28 | |
| 17 | 2016 | 26 | |
| 18 | 2017 | 25 | |
| 19 | 2019 | 22 | |
| 20 | 2019 | 20 |
About Zhenlin Yan
Zhenlin Yan is a scholar working on Hepatology, Surgery, Cancer Research, Epidemiology and Molecular Biology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers), Ubiquitin and proteasome pathways (1 paper), Telomeres, Telomerase, and Senescence (1 paper), Gallbladder and Bile Duct Disorders (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Hepatology (652 citations), Surgery (676 citations), Oncology (332 citations), Cancer Research (178 citations) and Pulmonary and Respiratory Medicine (310 citations). Zhenlin Yan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Feng Shen, Yong Xia, Kui Wang, Mengchao Wu, Jun Li, Lehua Shi, Dong Wu, Xuying Wan, Guanghua Liu and Renyan Gong. Their work appears in journals such as Oncotarget, Annals of Surgical Oncology, Hepatology, Journal of Gastroenterology and Hepatology and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.